[HTML][HTML] Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA …
B Singh, YC Hsieh, YB Liu, KH Lin, B Joung… - Indian Heart …, 2023 - Elsevier
Abstract Background & Objective Despite the burden of sudden cardiac arrest (SCA)
worldwide, implantable cardioverter-defibrillators (ICDs) are underutilized, particularly in …
worldwide, implantable cardioverter-defibrillators (ICDs) are underutilized, particularly in …
Role of implantable defibrillators in primary prevention of mortality in non-ischemic cardiomyopathy patients
A Akinapelli, A Patel, A Saadi, MS Azzouz… - Journal of the American …, 2017 - jacc.org
Background: Implantable cardioverter defibrillator (ICDs) have been shown to reduce all-
cause mortality in patients with ischemic and non-ischemic cardiomyopathy (NICM) …
cause mortality in patients with ischemic and non-ischemic cardiomyopathy (NICM) …
Implantable cardioverter defibrillator for the prevention of mortality in non-ischemic cardiomyopathy: a meta-analysis of randomized controlled trials
Background: The survival benefit of Implantable cardioverter defibrillator (ICD) in ischemic
cardiomyopathy with an ejection fraction (EF) of≤ 35% is well established. However, there …
cardiomyopathy with an ejection fraction (EF) of≤ 35% is well established. However, there …
Implantable cardioverter defibrillators for primary prevention of mortality in patients with nonischemic cardiomyopathy: a meta‐analysis of randomized controlled trials
S Stavrakis, Z Asad, D Reynolds - Journal of cardiovascular …, 2017 - Wiley Online Library
ICD for Nonischemic Cardiomyopathy Background Implantable cardioverter defibrillators
(ICDs) improve survival in patients with heart failure due to ischemic cardiomyopathy, but …
(ICDs) improve survival in patients with heart failure due to ischemic cardiomyopathy, but …
Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic review and meta-analysis of prospective randomized clinical trials
Introduction A mortality benefit in patients with implantable cardioverter defibrillator (ICD) in
ischemic cardiomyopathy is well established. However, the benefit of ICD implantation in …
ischemic cardiomyopathy is well established. However, the benefit of ICD implantation in …
[HTML][HTML] Implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a meta-analysis of randomized controlled trials
A Masri, M Hammadah, E Adelstein… - Cardiovascular …, 2017 - ncbi.nlm.nih.gov
Background Sudden cardiac death (SCD) is a significant cause of mortality in patients with
non-ischemic cardiomyopathy (NICM). Implantable cardioverter defibrillators (ICDs) are …
non-ischemic cardiomyopathy (NICM). Implantable cardioverter defibrillators (ICDs) are …
The mortality analysis of primary prevention patients receiving a cardiac resynchronization defibrillator (CRT‐D) or implantable cardioverter‐defibrillator (ICD) …
CK Ching, YC Hsieh, YB Liu… - Journal of …, 2021 - Wiley Online Library
Background In primary prevention (PP) patients the utilization of implantable cardioverter‐
defibrillators (ICD) and cardiac resynchronization therapy‐defibrillators (CRT‐D) remains …
defibrillators (ICD) and cardiac resynchronization therapy‐defibrillators (CRT‐D) remains …
Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of …
Aim Primary prophylactic implantable cardioverter defibrillators (ICDs) have demonstrated a
clear all-cause mortality benefit in patients with ischaemic cardiomyopathy, with less …
clear all-cause mortality benefit in patients with ischaemic cardiomyopathy, with less …
Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta‐analysis
T Akel, J Lafferty - Cardiovascular Therapeutics, 2017 - Wiley Online Library
Background Implantable cardioverter defibrillators (ICD s) have proved their favorable
outcomes on survival in selected patients with cardiomyopathy. Although previous meta …
outcomes on survival in selected patients with cardiomyopathy. Although previous meta …
Implantable cardiac defibrillator and mortality in non-ischaemic cardiomyopathy: an updated meta-analysis
AC Alba, F Foroutan, JD Posada, L Battioni, T Schofield… - Heart, 2018 - heart.bmj.com
Objectives The benefit of implantable cardiac defibrillator (ICD) in symptomatic patients with
systolic dysfunction and non-ischaemic cardiomyopathy remains controversial. We …
systolic dysfunction and non-ischaemic cardiomyopathy remains controversial. We …